 View / download form (375 KBytes) |
Part 5: The Russian pharmaceuticals market is growing very fast, and the clinical trials sector is booming. But any company that wants to do business there faces considerable challenges
The pharmaceuticals market in the Russian Federation is growing very rapidly, with six consecutive years of economic growth and a corresponding rise in living standards. But the state-run healthcare system is seriously under-funded and most Russians cannot afford the best new drugs. Moreover, the country still suffers from Soviet-style management practices; political interference remains a real risk; and the administrative and legal system is very weak. Russia thus offers genuine opportunities both for selling and testing pharmaceuticals, but these opportunities come with some substantial challenges.
Publications Search Page
